4DN Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Denali Therapeutics Inc

Watchlist Manager

Watchlist

Price: 21.31 EUR 1.33%

Market Cap: €5.9B

D	Denali Therapeutics Inc SWB:4DN	US
	Nelson Resources Ltd ASX:NES	AU
	Black Canyon Ltd ASX:BCA	AU
	Spartoo SAS SA PAR:ALSPT	FR
	Scottie Resources Corp F:SR80	CA
A	Alpha Cognition Inc OTC:ACOGF	CA
N	Nara Space Technology Inc KOSDAQ:478340	KR
	Sure Ventures PLC F:08F	UK
P	Play2Chill SA F:688	PL
	111 Inc NASDAQ:YI	CN
R	Republic Digital Acquisition Co NASDAQ:RDAG	US
B	Battery Minerals Ltd OTC:BTRYF	AU
R	Roctec Global PCL SET:ROCTEC	TH
S	Samkee Corp KOSDAQ:122350	KR
C	Changs Ascending Enterprise Co Ltd TPEX:8038	TW
	Indocan Resources Inc OTC:IDCN	CA

Profitability Summary

Denali Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

97%

Sustainable 3Y Average Gross Margin

19%

Negative Operating Margin

-15 058%

Negative 3Y Average Operating Margin

-10 673%

Declining Operating Margin

-48% > -15 058%

Negative Net Margin

-14 191%

Negative 3Y Average Net Margin

-9 320%

Declining Net Margin

-37% > -14 191%

Negative Free Cash Flow Margin

-12 937%

Negative 3Y Average Free Cash Flow Margin

-8 848%

Declining Free Cash Flow Margin

-94% > -12 937%

Negative ROE

-55%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-134%

Declining ROIC

-101% > -157%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.